Last reviewed · How we verify
NCT03642392
Identification and Treatment of Early Tendinopathy in Elite Athletes
trial testing Identification and treatment of early tendinopathy in Tendinopathy in 70 participants. Status unknown.
17 August 2020
Quick facts
| Lead sponsor | Bispebjerg Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 17 August 2018 |
| Primary completion | 17 August 2020 |
| Estimated completion | 17 August 2021 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Identification and treatment of early tendinopathy
Conditions studied
- Tendinopathy — all drugs for Tendinopathy →
Sponsor
Bispebjerg Hospital
Who can join
Adults 18 to 40, any sex, with Tendinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Tendon injuries represent a significant problem in elite athletes. The understanding of the pathophysiology of tendinopathy is very sparse, and especially the early events in tendinopathy are unknown. In this study, the investigators will investigate early changes in tendon tissue overloading and development of tendinopathy. The investigators will examine elite athletes with recently developed tendinopathy with regards to symptoms (pain, function), tendon morphology (ultrasonography, MRI), inflammation (the activity of inflammatory pathways) and vascularization (Doppler US). The investigators hypothesize a coupling between early symptoms and inflammatory activity, followed by structural changes. The investigation will indicate what symptoms and what tendon related measurements are primary for disease development ("tendinopathy blueprints") and should be regarding vital in the prevention of tendinopathy.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Assessment of the Psychometric Properties of the Danish VISA-P.
Agergaard AS, Comins JD, Siersma V, Malmgaard-Clausen NM, et al · · 2023 · cited 2× · PMID 38654908 · DOI 10.1155/2023/5291949 -
One-Year Follow-Up of Clinical and Morphological Outcomes in Elite Athletes With Early-Stage Lower Extremity Tendinopathy.
Seidler M, Svensson RB, Meulengracht C, Christensen KØ, et al · · 2025 · PMID 40261829 · DOI 10.1002/ejsc.12303
Verify or expand the search:
- PubMed search for NCT03642392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tendinopathy
Currently open trials in the same condition.
- NCT07231471 — Platelet Rich Plasma for Musculoskeletal Conditions · NA · recruiting
- NCT07025668 — The Effectiveness of Different Exercise Approaches in Biceps Brachii Long Head Tendinopathy · NA · recruiting
- NCT06095050 — Embolization Treatment of Chronic Refractory Shoulder Tendinopathy · NA · recruiting
- NCT06639308 — Eendoscopic Versus Open Flexor Hallucis Longus Transfer in Managing Various Tendon Achilles Disorders · NA · active not recruiting
- NCT06160427 — Connective Tissue Matrix for Rotator Cuff Tendinopathy · Phase 4 · active not recruiting
Other Bispebjerg Hospital trials
Trials by the same sponsor.
- NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
- NCT07373587 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy · NA · not yet recruiting
- NCT07123558 — Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men · NA · not yet recruiting
- NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
- NCT07096648 — Alert Burden When Monitoring Patients at Home · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03642392 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bispebjerg Hospital
- Last refreshed: 4 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03642392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing